HUMAN IGM MYELOMA (C15-1303-235)

General description

Native IgM from human myeloma plasma.

Packaging

Please refer to vial label for lot-specific concentration.

Warning

Toxicity: Standard Handling (A)

Physical form

In 200 mM NaCl, 50 mM Tris, pH 8.0.

Preparation Note

Prepared from plasma that was shown by certified tests to be negative for HBsAg and antibodies to HIV-1, HIV-2, and HCV.

Reconstitution

Following initial thaw, aliquot and freeze (-20°C).

Analysis Note

Single arc by IEP

Other Notes

Dilute with aqueous buffer with a pH range between 7.0 and 8.0 with isotonic salt conditions. IgM precipitates in low ionic strength solutions. Variables associated with assay conditions will dictate the proper working dilution.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Assay: ≥. 95% (SDS-PAGE). Quality Level: 100. form: liquid. contains: ≤. 0.1% sodium azide as preservative. manufacturer/tradename: Calbiochem^®. . storage condition: OK to freeze, avoid repeated freeze/thaw cycles. shipped in: wet ice. storage temp.: −. 20°C. target post-translational modification: unmodified. Storage Class Code: 10 - Combustible liquids. WGK: WGK 1. Flash Point(F): Not applicable. Flash Point(C): Not applicable.